Theravance's Gut-Selective JAK Inhibitor Disappoints In Ulcerative Colitis Study

Crohn's Disease Data Awaited On Izencitinib

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.